PW Medtech Group Ltd. is an investment holding company, which engages in the manufacture and sale of infusion set products. The company is headquartered in Beijing, Beijing and currently employs 1,356 full-time employees. The company went IPO on 2013-11-08. The firm operates its businesses through three segments. Infusion Set Business segment is mainly engaged in the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. Blood Purification Business segment is mainly involved in the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. Regenerative Medical Biomaterials Business segment is mainly involved in the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The firm mainly operates its businesses in the domestic market.
01358.HK stock price ended at $1.32 on 星期五, after rising 0.00%
On the latest trading day Feb 13, 2026, the stock price of 01358.HK rose by 0.00%, climbing from $1.32 to $1.32. During the session, the stock saw a volatility of 0.76%, with prices oscillating between a daily low of $1.32 and a high of $1.33. Notably, trading volume dropped by 512.0K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 601.0K shares were traded, equating to a market value of approximately $1.9B.